PT - JOURNAL ARTICLE AU - Shamam Waldman AU - Daniel Backenroth AU - Éadaoin Harney AU - Stefan Flohr AU - Nadia C. Neff AU - Gina M. Buckley AU - Hila Fridman AU - Ali Akbari AU - Nadin Rohland AU - Swapan Mallick AU - Jorge Cano Nistal AU - Jin Yu AU - Nir Barzilai AU - Inga Peter AU - Gil Atzmon AU - Harry Ostrer AU - Todd Lencz AU - Yosef E. Maruvka AU - Maike Lämmerhirt AU - Leonard V. Rutgers AU - Virginie Renson AU - Keith M. Prufer AU - Stephan Schiffels AU - Harald Ringbauer AU - Karin Sczech AU - Shai Carmi AU - David Reich TI - Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14<sup>th</sup> century AID - 10.1101/2022.05.13.491805 DP - 2022 Jan 01 TA - bioRxiv PG - 2022.05.13.491805 4099 - http://biorxiv.org/content/early/2022/05/16/2022.05.13.491805.short 4100 - http://biorxiv.org/content/early/2022/05/16/2022.05.13.491805.full AB - We report genome-wide data for 33 Ashkenazi Jews (AJ), dated to the 14th century, following a salvage excavation at the medieval Jewish cemetery of Erfurt, Germany. The Erfurt individuals are genetically similar to modern AJ and have substantial Southern European ancestry, but they show more variability in Eastern European-related ancestry than modern AJ. A third of the Erfurt individuals carried the same nearly-AJ-specific mitochondrial haplogroup and eight carried pathogenic variants known to affect AJ today. These observations, together with high levels of runs of homozygosity, suggest that the Erfurt community had already experienced the major reduction in size that affected modern AJ. However, the Erfurt bottleneck was more severe, implying substructure in medieval AJ. Together, our results suggest that the AJ founder event and the acquisition of the main sources of ancestry pre-dated the 14th century and highlight late medieval genetic heterogeneity no longer present in modern AJ.Competing Interest StatementShai Carmi is a paid consultant and holds stock options at MyHeritage. Daniel Backenroth is an employee and shareholder at The Janssen Pharmaceutical Companies of Johnson &amp; Johnson. Eadaoin Harney is an employee of 23andMe.